Neuroscience
Dopamine Receptor D2
100%
Positron Emission Tomography
97%
Istradefylline
80%
Striatum
80%
Adenosine
76%
Parkinson's Disease
73%
Microglia
71%
Adenosine A2A Receptor
69%
Dopaminergic
66%
Receptor Antagonist
66%
Behavior (Neuroscience)
65%
Raclopride
56%
Lipopolysaccharide
52%
Eicosanoid Receptor
49%
Social Defeat
40%
Cell Density
37%
Female Rats
33%
CGS-21680
33%
Receptor Agonists
33%
Encephalopathy
33%
In Vivo
29%
Social Behavior
27%
Dementia Praecox
20%
Hippocampus
20%
Anhedonia
19%
Frontal Lobe
18%
Dopaminergic Neuron
15%
Social Interaction
15%
Corticosterone
14%
Substance Abuse
13%
Cell Signaling
13%
Astrocyte
13%
Attention Deficit Hyperactivity Disorder
13%
Medium Spiny Neuron
13%
Motor Control
13%
Nucleus Accumbens
13%
Biomembrane
13%
Tyrosine Hydroxylase
13%
Cerebellum
12%
Polyinosinic:polycytidylic Acid
12%
Translocator Protein
11%
Locomotion
11%
Positron Emission Tomography
10%
Agonist
9%
Oxidopamine
7%
Pervasive Developmental Disorder
6%
Imaging Technique
6%
Mental Disorder
6%
Bipolar Depression
6%
Mood Disorder
6%
Medicine and Dentistry
Parkinson's Disease
66%
Neuroinflammation
66%
Istradefylline
66%
Dopaminergic System
66%
Striatum
47%
Carbon 11
46%
Adenosine
36%
Motor Performance
33%
Receptor Antagonist
33%
Raclopride
23%
Contralateral
15%
Dopaminergic Neuron
15%
Symptom
15%
Positron Emission Tomography
14%
Tyrosine 3 Monooxygenase
13%
Positron Emission Tomography
10%
Oxidopamine
7%
Keyphrases
Motor Performance
33%
Adenosine A2A Receptor Antagonist
33%
D2 Receptor Ligands
33%
Dopaminergic System
33%
A2A Antagonists
33%
Rat Model of Parkinson's Disease
33%
KW-6002
33%
Striatum
33%
Neuroinflammation
33%
Tumor-infiltrating Macrophages
33%
Post-mortem Analysis
9%
PBR28
9%
A2A Agonist
9%
6-hydroxydopamine (6-OHDA)
9%
PET Scan
9%
Parkinson's Disease Model
9%
Motor Function
9%
Dopaminergic Neuron Loss
9%
Raclopride
9%
Allosteric Receptor-receptor Interactions
8%
Heterobivalent
8%
